Emerald Medical Applications Corp. - Statements of Cash Flows	9 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)
Cash flows from operating activities:
Net loss	(3,763,575)	(7,675,156)
Depreciation expense	3,392	4,123
Amortization of debt discount	211,720	9,555
Change in fair value of derivative liabilities	0	(367)
Extinguishment of derivative	0	(20,165)
Shares issued for services	2,766,823	617,900
Warrants issued for services	0	5,343,088
Loss on settlement of debt	0	678,027
Adjustments to reconcile net loss to net cash used in operating activities:
Decrease (increase) in other accounts receivable	$ 20,231	$ (5,094)
Increase in accounts payable	(81,012)	131,553
Increase in related parties payable	$ 509	$ 11,607
Increase in employees payables	38,021	48,506
Increase in amounts due from related party	0	18,999
Increase in accrued interest	$ 1,025	$ 5,431
Cash flows used by operating activities	$ (802,866)	$ (831,993)
Cash flows from investing activities:
Purchase of property and equipment	0	(26,002)
Effect of reverse merger	0	467,380
Net cash provided by investing activities	$ 0	$ 441,378
Cash flows from financing activities:
Proceeds from sale of common stock (net of issuance expenses)	783,049	280,000
Issuance of short-term payable	0	572,071
Cash provided by financing activities	$ 783,049	$ 852,071
Foreign currency adjustment	(23,865)	(28,847)
Net increase (decrease) in cash	$ (43,682)	$ 432,618
Cash and cash equivalents - beginning of period	115,449	14,411
Cash and cash equivalents - end of period	71,767	447,029
Non-cash transaction:
Shares issued for reverse merger	0	547
Debt settled with stock	0	91,687